AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today ...

AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay(TM) blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced ...

AUXVASSE, Mo.--(BUSINESS WIRE)--Sinclair Research, a leading provider of nonclinical contract research services, today announced completion of successful validation of GLP ototoxicity testing services ...

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...

Early data regarding the use of GLP-1 medications like Ozempic and Wegovy to treat addiction is “very, very, exciting,” Nora Volkow, the director of the National Institute on Drug Abuse, said Thursday ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

– New Data Suggests that IMU-856 Could Be a Potential Oral Treatment Option for Weight Management; Program Is Phase 2 Ready – – Dose-Dependent Increase of Endogenous GLP-1 Levels Observed in Post Hoc ...

– New Data Suggests that IMU-856 Could Be a Potential Oral Treatment Option for Weight Management; Program Is Phase 2 Ready – – Dose-Dependent Increase of Endogenous GLP-1 Levels Observed in Post Hoc ...